EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Doseology Sciences's enterprise value is C$0.52 Mil.
Doseology Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.08 Mil. Therefore, Doseology Sciences's EV-to-Revenue for today is 6.46.
The historical rank and industry rank for Doseology Sciences's EV-to-Revenue or its related term are showing as below:
XCNQ:MOOD'
s EV-to-Revenue Range Over the Past 10 Years
Min: -19.51 Med: 9.05 Max: 122.11
Current: 6.46
During the past 4 years, the highest EV-to-Revenue of Doseology Sciences was 122.11. The lowest was -19.51. And the median was 9.05.
XCNQ:MOOD's EV-to-Revenue is ranked better than 55.15% of 1039
companies
in the Biotechnology industry
Industry Median: 8.18
vs XCNQ:MOOD: 6.46
The historical data trend for Doseology Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Doseology Sciences's EV-to-Revenue
For the Biotechnology subindustry, Doseology Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doseology Sciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Doseology Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Doseology Sciences's EV-to-Revenue falls into.
Doseology Sciences's current Enterprise Value is C$0.52 Mil.
Doseology Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doseology Sciences's share price for today is C$0.37.
Doseology Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doseology Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Doseology Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Doseology Sciences (XCNQ:MOOD) Business Description
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:MOOD has been successfully added to your 